King Pharmaceuticals KG Program Services — Operating Expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's program services — operating expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's program services — operating expenses?
- King Pharmaceuticals (KG) reported program services — operating expenses of $1.51M in Q1 2026.
- How has King Pharmaceuticals's program services — operating expenses changed year-over-year?
- King Pharmaceuticals's program services — operating expenses increased by 164.3% year-over-year, from $572K to $1.51M.
- What does program services — operating expenses mean?
- General and administrative costs incurred to support the operations of the program services segment. Monitoring these expenses is essential for assessing the segment's operational leverage and cost management discipline.